COMMUNIQUÉS West-GlobeNewswire

Ceribell to Participate in Upcoming March Investor Conferences
18/02/2026
SUNNYVALE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Canadian Red Cross supporting people directly impacted by the Tumbler Ridge tragedy
18/02/2026
Red Cross appealing for additional funds OTTAWA, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is asking for additional donations to the Tumbler Ridge Tragedy Appeal to help ensure sustained support [...]
Cree Board of Health and Social Services of James Bay and the Canadian Red Cross gather to recognize the culmination of years of development on the Nâtimâchâukimikw – Mobile Health Unit in Chisasibi
18/02/2026
Winter exercise brings mobile healthcare closer to remote northern communities CHISASIBI, Quebec, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The Cree Board of Health and Social Services of James Bay (CBHSSJB), in partnership [...]
Après plusieurs années de travail, le Conseil cri de la santé et des services sociaux de la Baie James et la Croix-Rouge canadienne célèbrent l’aboutissement du projet Nâtimâchâukimikw – Unité de santé mobile à Chisasibi
18/02/2026
Les soins de santé mobiles se rapprochent des communautés nordiques isolées à l’occasion d’un exercice hivernal CHISASIBI, Québec, 18 févr. 2026 (GLOBE NEWSWIRE) -- Le Conseil cri de la santé et des services sociaux de [...]
Aeroflow Health President Named to The Healthcare Technology Report's Top Women Leaders In Healthcare Technology List of 2025
18/02/2026
Lauren Bennett is recognized for her role in leading Aeroflow Health's transformation into a national, patient-focused healthcare technology company ASHEVILLE, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health, a [...]
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer
18/02/2026
CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced continued expansion of its [...]
La Croix-Rouge canadienne vient en aide aux personnes éprouvées par la tragédie de Tumbler Ridge
18/02/2026
La Croix-Rouge sollicite des fonds supplémentaires OTTAWA, Ontario, 18 févr. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne sollicite des dons supplémentaires dans le cadre du Fonds de soutien : Tragédie de Tumbler [...]
UPDATE – Health Systems and Strategic Partners Unite to Address Widening Healthcare Gaps in Rural and Underserved Communities
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The National Specialty Care Access Coalition (NSCAC), a collaboration of more than 20 major US health systems, today announced its launch to address the growing breakdown in [...]
Design Therapeutics to Participate in Upcoming Investor Conferences
18/02/2026
CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
Tenvie Therapeutics Appoints Don O’Sullivan, Ph.D., MBA, as Chief Business Officer
18/02/2026
Seasoned biotechnology executive with more than 20 years of corporate and business development experience to lead strategic collaborations and business operations BRISBANE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Health Systems and Strategic Partners Unite to Address Widening Healthcare Gaps in Rural and Underserved Communities
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The National Specialty Care Access Coalition (NSCAC), a collaboration of more than 20 major US health systems, today announced its launch to address the growing breakdown in [...]
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
18/02/2026
- Data presented at Annual Winter Meeting 2026 for the Vascular & Endovascular Surgery Society - - After up to 36 months of follow-up, extremity arterial trauma patients had high rates of limb salvage, low rates of [...]
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
18/02/2026
SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Genelux Corporation to Participate in Upcoming Conferences
18/02/2026
WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation ( NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that the Company will participate in two upcoming [...]
LIXTE Biotechnology Appoints Sidney Braun as CEO of its Liora Technologies Europe Ltd. Subsidiary
18/02/2026
BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer [...]
Elicio Therapeutics Reports Inducement Grants
18/02/2026
BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
18/02/2026
WALTHAM, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of [...]
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
18/02/2026
Tumor Shrinkage of 50% and significant CA-125 biomarker reduction observed at 220 mg dose level Patient experienced only Grade 1 adverse events Represents second patient with PR to harbor PPP2R1A mutation, supporting [...]
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
18/02/2026
SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA [...]

Pages